Loading Events

« All Events

  • This event has passed.

November 8 @ 4:00 pm - 7:00 pm

Share Celebration Networking Event

2nd Annual Invented at Duke Celebration


2nd Invented at Duke Celebration

Duke OLV and Duke I&E’s #InventedatDuke Celebration is an opportunity to meet with University researchers commercializing technologies generated by the more than $1 billion in research conducted annually at Duke.

Join us and discover how Duke has been innovating this year. Connect with Alumni, entrepreneurs, CEOs, and investors while exploring our featured innovators as they show off their inventions and novel ideas.

This event will honor this past year’s Duke faculty, staff, and student innovators whose research and ideas have the potential to improve and save lives.

After drinks and hors d’oeuvres, we will hear special remarks around 5:30 from this year’s special guest speaker Nathan Kundtz, CEO of Kymeta, a company spun out of the David Smith labs at Pratt Engineering. Learn more about Kymeta

If you are an inventor, researcher, licensee, investor, entrepreneur or someone interested in partnering with Duke, we hope you’ll join us for our 2nd Annual #InventedAtDuke Celebration.

RSVP Here

CHECK OUT LAST YEAR’S EVENT

 

**Please note: We will have shuttles running continuously from the Washington Duke/JB Duke to Penn Pavilion. Starting at 6 pm, we will have shuttles running to the Chesterfield for Pratt’s BOV cocktail party**

Featured Innovators

  • Cereius aims to improve the lives and survival of patients facing solid tumor brain metastasis through the use of personalized and highly targeted radiotherapy.

Inventors: Mike Zalutsky (Radiology) and Ganesan Vaidyanathan (Radiology)

CEO: Ed Field (Duke Alumni and President of BioLabs, North Carolina)

 

  • TRPblue is a therapeutics company developing a unique, dual acting inhibitor that targets transient receptor potential (TRP) cation channels TRPV4 and TRPA1. TRPblue has developed small molecule antagonists that preferentially attenuate signaling of these calcium-permeable channels with proven efficacy in several acute pain and chemical denervation nerve-pain models. These inhibitors have also demonstrated anti-pruritic, anti-fibrotic and anti-inflammatory activity in relevant preclinical models. The team will develop a topically applied, highly tolerated go-to dermatology therapeutic.

Inventor: Wolfgang Liedtke (Neurology)

Management: Barney Koszalka

 

  • Tellus Therapeutics is a mission-driven life sciences company founded in 2018 to translate groundbreaking research by Duke neonatologist and stem cell biologist, Eric Benner, MD/ Ph.D., into a treatment for babies born with brain injury. One in ten babies is born premature and at significant risk for white matter (myelin) injury and subsequent life-long cognitive and neurological impairments, such as cerebral palsy. Tellus is developing novel small molecules derived from human maternal breast milk demonstrated to induce regeneration of myelin-producing oligodendrocytes, reverse white matter injury in animal models of perinatal brain injury and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury for whom no treatments are available.

Inventor: Eric Brenner

Management: Jason Kralic

 

  • Realtime Robotics have invented a specialized processor for generating safe robot motion plans in microseconds, enabling robots to function in unstructured, collaborative workspaces, reacting to other movements as soon as they are perceived.

Inventor: Dan Sorin (Electrical & Computer Engineering)

CEO: Peter Howard (Four startups, two IPOs, one strategic exit in robotics)

 

  • Zephyr Mobility is collaborating with Duke Health to develop a bariatric patient handling device for nurses in the hospital. 75% of patients need to be turned side to side every two hours, but current methods are back-breaking and labor-intensive for nurses. Our mechanical system accomplishes the task at the push of a button, which will improve patient outcomes, reduce caregiver back strain, and improve staff productivity across the hospital. Duke Health is providing major R&D support with seed funding, access to end users and key administrators, personnel and facilities for field testing, and clinical mentorship.

Inventor: Sam Fox (Pratt Grad)

 

  • TAMS, Teaching Assignment Management System is a software application developed at the School of Nursing that helps predict teaching efforts needed for university courses and assign faculty to those courses. This has been recently licensed to George Washington, and University of Illinois

Inventors: David Bowersox/David Parrish (Nursing)

Management: Michael Evans

 

  • Carpe Lotion is the developer of antiperspirant solutions for all the neglected, sweaty areas of the body: Hands, feet, and soon, far more. Our mission is simple: Stop the sweat, no matter where you sweat, why you sweat, or how you sweat. Founded by then-UNC sophomore David Spratte and Duke sophomore Kasper Kubica in 2014, Carpe has grown into a top-selling brand on Amazon, and reached millions of Americans with its nationwide presence at CVS.

Co-Inventor: Kasper Kubica (Duke Grad)

  • 374 Water is the future of water treatment. This startup company is changing the waste treatment paradigm by using supercritical water oxidation (SCWO) technology which converts organic waste to clean water in seconds.
    Over the past 6 years, a team led by Prof. Deshusses at Duke University has been developing and demonstrating a breakthrough waste treatment technology that is sustainable, cost-effective and offers superior wastewater treatment. Supercritical water oxidation relies on the unique properties exhibited when water or slurries are brought above the critical point of water 374°C (705 °F) and 221 bar (3200 psi). Under these conditions, organic waste is quickly converted in a single stage to clean water, carbon dioxide (that can be recovered), some non-leachable inorganic salts, and net energy from the heat of reaction. All pathogens and micro-pollutant are destroyed and no chemicals or catalysts are needed. Depending on the waste being treated, SCWO units could work off the grid and generate a surplus of energy.374Water is commercializing the SCWO technology by globally deploying prefabricated modular units that treat fecal waste, biosolids, or agricultural waste by 2020.

Inventors: Marc Deshusses &  Kobe Nagar

Venue

Penn Pavilion
107 Union Dr
Durham, NC 27710 United States
+ Google Map